Scarica l'app Stockscreener
2.08
1.89%
-0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.12
Aprire:
$2
Volume 24 ore:
132.55K
Relative Volume:
1.87
Capitalizzazione di mercato:
$84.96M
Reddito:
$2.70M
Utile/perdita netta:
$5.53M
Rapporto P/E:
18.91
EPS:
0.11
Flusso di cassa netto:
$-10.55M
1 W Prestazione:
-0.48%
1M Prestazione:
-0.48%
6M Prestazione:
-13.33%
1 anno Prestazione:
-11.49%
Intervallo 1D:
$1.975
$2.1242
Intervallo di 1 settimana:
$1.975
$2.143
Portata 52W:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Nome
Oramed Pharmaceuticals Inc
Settore
Industria
Telefono
646-844-1164
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Confronta ORMP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.08 | 86.59M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Iniziato | Canaccord Genuity | Buy |
| 2021-02-09 | Iniziato | National Securities | Buy |
| 2020-12-03 | Iniziato | Alliance Global Partners | Buy |
| 2020-03-11 | Iniziato | Aegis Capital | Buy |
| 2019-09-11 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-12-11 | Ripresa | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Reiterato | FBR Capital | Outperform |
| 2015-12-01 | Reiterato | H.C. Wainwright | Buy |
| 2015-11-19 | Iniziato | FBR Capital | Outperform |
| 2015-04-13 | Ripresa | MLV & Co | Buy |
| 2014-01-30 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Iniziato | MLV & Co | Buy |
| 2013-12-03 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie
Risk vs reward if holding onto Oramed Pharmaceuticals Inc.Quarterly Profit Report & Expert Approved Momentum Ideas - Newser
Backtesting results for Oramed Pharmaceuticals Inc. trading strategiesJuly 2025 Opening Moves & Community Consensus Stock Picks - Newser
How high can Oramed Pharmaceuticals Inc. stock price go in 2025Portfolio Update Summary & Reliable Intraday Trade Plans - Newser
Is now a turning point for Oramed Pharmaceuticals Inc.July 2025 Recap & Low Risk Growth Stock Ideas - Newser
Detecting price anomalies in Oramed Pharmaceuticals Inc. with AIJuly 2025 Pullbacks & Entry Point Strategy Guides - Newser
Can a trend reversal in Oramed Pharmaceuticals Inc. lead to recoveryEarnings Growth Report & Verified Technical Signals - Newser
Oramed: Q2 Earnings Snapshot - Norwalk Hour
What candlestick patterns are forming on Oramed Pharmaceuticals Inc.July 2025 Closing Moves & High Return Stock Watch Alerts - Newser
Oramed Pharmaceuticals: Navigating Earnings Volatility and Strategic Alliances in a High-Stakes Biotech Landscape - AInvest
Published on: 2025-08-14 06:23:37 - Newser
Oramed Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowQuarterly Profit Report & Fast Entry Momentum Trade Alerts - Newser
Oramed Pharmaceuticals shares rise 1.82% premarket after reporting Q1 revenue of $2 million. - AInvest
Can machine learning forecast Oramed Pharmaceuticals Inc. recoveryEarnings Summary Report & Real-Time Buy Signal Alerts - Newser
Scilex Holding Company Announces S-4 Effectiveness, Denali-Semnur Merger Proposal, and Oramed Pharmaceuticals Enters Option Agreement with Scilex - AInvest
Is Oramed Pharmaceuticals Inc. forming a reversal patternJuly 2025 Levels & Verified Swing Trading Watchlist - Newser
Can volume confirm reversal in Oramed Pharmaceuticals Inc.2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
How to use Fibonacci retracement on Oramed Pharmaceuticals Inc.2025 Market Outlook & Smart Swing Trading Alerts - Newser
How high can Oramed Pharmaceuticals Inc. stock goFree Watchlist for Low Risk High Return - Newser
How Oramed Pharmaceuticals Inc. stock performs during market volatilityFree Daily Chart Pattern Stock Forecast - Newser
Alpha Tau Secures FDA Approval for Breakthrough Brain Cancer Treatment Trial, Raises $36.9M - Stock Titan
What to expect from Oramed Pharmaceuticals Inc. in the next 30 daysFree Stock Market Entry Timing Signals - Newser
Can you recover from losses in Oramed Pharmaceuticals Inc.Free Short Term High Yield Stock Tips - Newser
Published on: 2025-08-10 20:12:47 - Newser
Intraday pattern recognizer results for Oramed Pharmaceuticals Inc.Daily Exit and Entry Price Prediction - Newser
Oramed Pharmaceuticals Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Diabetic Ketacidosis Treatment Market Set to Witness - openPR.com
What makes Oramed Pharmaceuticals Inc. stock price move sharplyMulti-Year Investment Performance Summary Report - Newser
Published on: 2025-08-05 21:05:42 - Newser
Recovery Signals Appearing in Oramed Pharmaceuticals Inc. ChartsReal Trader Watchlist of Hot Stocks Released - beatles.ru
How does Oramed Pharmaceuticals Inc. generate profit in a changing economyIdentify winners with top-tier analysis - Jammu Links News
What are analysts’ price targets for Oramed Pharmaceuticals Inc. in the next 12 monthsBuild wealth steadily with expert advice - Jammu Links News
How does Oramed Pharmaceuticals Inc. compare to its industry peersTriple-digit wealth increases - Jammu Links News
Should I hold or sell Oramed Pharmaceuticals Inc. stock in 2025Maximize gains with expert analysis - Jammu Links News
Is it the right time to buy Oramed Pharmaceuticals Inc. stockFree Market Dynamics Reports - Jammu Links News
Oramed Pharmaceuticals Inc. Stock Analysis and ForecastDiscover high-impact stocks for your portfolio - Jammu Links News
Oramed Pharmaceuticals Inc Azioni (ORMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):